3Yamamoto Y,Toi M,Kondo S,et al.Concentrations of vascuLar endotheLiaL growth factor in zhe sera of normaL controLs and cancer patients[J].C Lin Cancer Res,1996,2:821.
4Tsai W S,Changchien C R,Yeh C Y,et al.Preoperative pLasma vascuLar endotheLiaL growth factor but not nitrite is a fusefuL compLementary tumor marker in patients with coLorectaL cancer[J].Dis CoLon Rectum,2006,49(6):883.
5CouLtas L,Chawengsaksophak K,Rossant J.EndotheLiaL ceLLs and VEGF in vascuLar deveLopment[J].Nature,2005,438(7070):937.
6De Gramont A,Figer A,Seymour M,et al.Leucovorin and fLuorouraciL with or without oxaLipLatin as first Line treatment in advanced coLorectaL cancer[J].J CLin OncoL,2000,18:2938.
7Lissoni P,RoveLLi F,MaLugani F,et al.Changes in circuLating VEGF LeveLs in reLation to cLinicaL response during chemotherapy for metastatic cancer[J].Iht d BioL Markers,2003,18(2):152.
8Yamamoto Y,Toi M,Kondo S. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients[J].{H}Clinical Cancer Research,2012,(30):748.
9Lissoni P,Rovelli F,Malugani F. Changes in circulating VEGF levels in relation to clinical response during chemotherapy for metastatic cancer[J].nternational Journal of Biological Markers,2010,(22):391-392.
10VAN CUTSEM E, COSTA F. Progress in the adjuvant treat- ment of colon cancer: has it influenced clinical practice [ J]. JAMA,2005,294(21 ) :2758 - 2760.
